loader
Please Wait
Applying Filters...

EuroAPI Header EuroAPI Header

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Certificates of Suitability (CEPs) for r1_cep_2004_235___rev_03 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    Client Virtual Booth
    Menu

    Takeda Pharmaceutical

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    With Fermion, start the journey of your innovative API.

    Send me more info on How To Grow My Business Digitally?

    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 TAKEDA AUSTRIA GMBH Linz AT (1)

    filter

    01 Deproteinised hemoderivative of calf blood, Actovegin concentrate (1)

    filter

    01 Japan (1)

    filter

    01 Valid (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    TAKEDA AUSTRIA GMBH Linz AT

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag Japan
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Deproteinised hemoderivative of calf blood, Actovegin c...

    PDF Supplier PDF
    URL Supplier Web Content
    R1-CEP 2004-235 - Rev 03
    Valid
    TSE
    2019-04-26
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Looking for Certificates of Suitability (CEPs) for R1-CEP 2004-235 - Rev 03 of Takeda Austria Gmbh Linz At

    Looking for Certificates of Suitability (CEPs) for R1-CEP 2004-235 - Rev 03 of Takeda Austria Gmbh Linz At 1

    20

    Takeda Austria Gmbh Linz At, based in Japan, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

    One of their significant offerings is Deproteinised hemoderivative of calf blood, Actovegin concentrate, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2004-235 - Rev 03

    This TSE Type CEP, issued on April 26, 2019, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.

    Post Enquiry
    POST ENQUIRY